title: Integration of multiple signaling regulates through apoptosis the differential osteogenic potential of neural crest-derived and mesoderm-derived Osteoblasts.
abstract: Neural crest-derived (FOb) and mesoderm-derived (POb) calvarial osteoblasts are characterized by distinct differences in their osteogenic potential. We have previously demonstrated that enhanced activation of endogenous FGF and Wnt signaling confers greater osteogenic potential to FOb. Apoptosis, a key player in bone formation, is the main focus of this study. In the current work, we have investigated the apoptotic activity of FOb and POb cells during differentiation. We found that lower apoptosis, as measured by caspase-3 activity is a major feature of neural crest-derived osteoblast which also have higher osteogenic capacity. Further investigation indicated TGF-β signaling as main positive regulator of apoptosis in these two populations of calvarial osteoblasts, while BMP and canonical Wnt signaling negatively regulate the process. By either inducing or inhibiting these signaling pathways we could modulate apoptotic events and improve the osteogenic potential of POb. Taken together, our findings demonstrate that integration of multiple signaling pathways contribute to imparting greater osteogenic potential to FOb by decreasing apoptosis.
authors.affiliation: Hagey Laboratory for Pediatric Regenerative Medicine, Department of Surgery, Stanford University, School of Medicine, Stanford, California, United States of America.
authors.forename: Shuli
authors.initials: S
authors.lastname: Li
authors.forename: Nathaniel P
authors.initials: NP
authors.lastname: Meyer
authors.forename: Natalina
authors.initials: N
authors.lastname: Quarto
authors.forename: Michael T
authors.initials: MT
authors.lastname: Longaker
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001549:Benzamides / Q000494:pharmacology; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002454:Cell Differentiation / Q000502:physiology*; D004149:Dioxoles / Q000494:pharmacology; D008648:Mesoderm / Q000378:metabolism*; D051379:Mice; D009432:Neural Crest / Q000378:metabolism*; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism*; D010012:Osteogenesis / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects; D016212:Transforming Growth Factor beta / Q000378:metabolism; D051153:Wnt Proteins / Q000378:metabolism
chemical_list: C459179:4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide; D001549:Benzamides; D019485:Bone Morphogenetic Proteins; D004149:Dioxoles; D016212:Transforming Growth Factor beta; D051153:Wnt Proteins
references.citation: Nitric Oxide. 2002 May;6(3):333-41
references.pmid: 12009851
references.citation: Calcif Tissue Int. 2003 Apr;72(4):505-12
references.pmid: 12532282
references.citation: Biochim Biophys Acta. 2012 Jan;1825(1):18-28
references.pmid: 21982838
references.citation: Stem Cells Dev. 2011 Feb;20(2):243-57
references.pmid: 20698749
references.citation: Stem Cells. 2012 Dec;30(12):2709-19
references.pmid: 23037987
references.citation: J Biol Chem. 2005 Dec 16;280(50):41342-51
references.pmid: 16251184
references.citation: Acta Pharmacol Sin. 2008 Dec;29(12):1425-31
references.pmid: 19026161
references.citation: J Biol Chem. 2000 Jun 9;275(23):17647-52
references.pmid: 10748100
references.citation: Development. 2000 Mar;127(5):1095-104
references.pmid: 10662648
references.citation: J Bone Miner Res. 1994 Mar;9(3):389-94
references.pmid: 8191933
references.citation: Mol Cell Biochem. 2008 Jun;313(1-2):71-8
references.pmid: 18385949
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L123-33
references.pmid: 18456797
references.citation: Dev Cell. 2011 Oct 18;21(4):627-41
references.pmid: 21982646
references.citation: J Cell Biochem. 2007 Oct 15;102(3):593-608
references.pmid: 17729308
references.citation: J Mol Cell Cardiol. 2012 Jan;52(1):237-44
references.pmid: 22064324
references.citation: Am J Physiol Cell Physiol. 2007 Dec;293(6):C1834-42
references.pmid: 17913846
references.citation: Biochem Biophys Res Commun. 2012 Jan 13;417(2):869-73
references.pmid: 22209843
references.citation: Respir Physiol Neurobiol. 2011 Aug 15;177(3):241-6
references.pmid: 21539941
references.citation: Growth Factors. 2004 Dec;22(4):233-41
references.pmid: 15621726
references.citation: J Biol Chem. 2003 Oct 31;278(44):43001-7
references.pmid: 12933797
references.citation: Development. 1997 Mar;124(6):1109-17
references.pmid: 9102298
references.citation: Front Physiol. 2011 Oct 24;2:78
references.pmid: 22028694
references.citation: Eur J Oral Sci. 1999 Aug;107(4):265-75
references.pmid: 10467942
references.citation: Nature. 2000 Oct 12;407(6805):770-6
references.pmid: 11048727
references.citation: Bone. 2010 Aug;47(2):281-94
references.pmid: 20472108
references.citation: Oncogene. 2012 May 31;31(22):2725-37
references.pmid: 22002305
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G514-9
references.pmid: 19608730
references.citation: Bone. 2013 Jan;52(1):145-56
references.pmid: 23032104
references.citation: Blood. 1996 Jul 15;88(2):386-401
references.pmid: 8695785
references.citation: Cells Tissues Organs. 2009;190(3):158-69
references.pmid: 19218784
references.citation: Cancer Cell Int. 2010 Jun 30;10:22
references.pmid: 20591184
references.citation: J Cell Physiol. 2011 Oct;226(10):2683-90
references.pmid: 21792926
references.citation: PLoS Genet. 2008 Feb;4(2):e7
references.pmid: 18248096
references.citation: Dev Biol. 2010 Aug 15;344(2):922-40
references.pmid: 20547147
references.citation: Endocrinology. 1999 Oct;140(10):4377-81
references.pmid: 10499488
references.citation: Calcif Tissue Int. 2006 May;78(5):293-301
references.pmid: 16604280
references.citation: Biochem Biophys Res Commun. 2003 Jan 31;301(1):84-91
references.pmid: 12535644
references.citation: Biochim Biophys Acta. 2009 Dec;1793(12):1819-27
references.pmid: 19782107
references.citation: Dev Biol. 2004 Apr 1;268(1):220-31
references.pmid: 15031118
references.citation: Mol Cancer Ther. 2006 Sep;5(9):2203-10
references.pmid: 16985053
references.citation: Stem Cells. 2004;22(1):74-85
references.pmid: 14688393
references.citation: Ann N Y Acad Sci. 2010 Mar;1192:330-7
references.pmid: 20392256
references.citation: Arch Med Res. 2008 Jul;39(5):467-82
references.pmid: 18514091
references.citation: Stem Cells. 2011 Dec;29(12):2018-29
references.pmid: 21997852
references.citation: Mol Pharmacol. 2002 Jul;62(1):65-74
references.pmid: 12065756
references.citation: Biochem Biophys Res Commun. 2005 Mar 18;328(3):709-20
references.pmid: 15694405
references.citation: PLoS One. 2011;6(10):e26371
references.pmid: 22028866
references.citation: J Bone Miner Res. 2010 Jul;25(7):1680-94
references.pmid: 19929441
references.citation: Cell Res. 2008 Feb;18(2):248-53
references.pmid: 18212734
references.citation: EMBO J. 2004 Feb 11;23(3):552-63
references.pmid: 14749725
references.citation: J Cell Biochem. 2002;84(4):816-31
references.pmid: 11835406
references.citation: J Bone Miner Res. 2008 Nov;23(11):1765-74
references.pmid: 18597629
references.citation: PLoS One. 2010 Nov 18;5(11):e14033
references.pmid: 21124973
references.citation: Glia. 2002 Oct;40(1):95-108
references.pmid: 12237847
references.citation: J Cell Biol. 2001 Jan 8;152(1):87-96
references.pmid: 11149923
references.citation: Dev Biol. 2002 Jan 1;241(1):106-16
references.pmid: 11784098
references.citation: Calcif Tissue Int. 2008 Mar;82(3):191-201
references.pmid: 18259679
references.citation: J Cell Sci. 2011 Oct 15;124(Pt 20):3428-40
references.pmid: 21984813
references.citation: J Biol Chem. 2005 Jul 22;280(29):27271-83
references.pmid: 15911626
references.citation: J Biol Chem. 2008 Mar 28;283(13):8412-22
references.pmid: 18204048
references.citation: Cancer Res. 2009 Mar 15;69(6):2185-90
references.pmid: 19276350
references.citation: J Anat. 2003 Dec;203(6):589-98
references.pmid: 14686694